Return to Listing

1 result(s) for

PI Name Protocol # Title
Jeremy Cetnar STUDY00019556 [NCI CIRB] S1900A - A Phase II Study of Rucaparib in Patients with Genomic LOH High and/or Deleterious BRAC1/2 Mutation Stage IV or Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub Study)
For more information:
Call: 503-494-1080